J. Singleton

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial.

J. D. Young, P. Robbins, T. Walsh, 2021, British journal of anaesthesia.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

-------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--.

A. von Kriegsheim, K. Dhaliwal, D. Cantrell, 2021, Wellcome open research.

A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS

A. von Kriegsheim, K. Dhaliwal, D. Cantrell, 2021, Wellcome open research.

Proteomics identifies a type I IFN, prothrombotic hyperinflammatory circulating COVID-19 neutrophil signature distinct from non-COVID-19 ARDS

K. Dhaliwal, D. Cantrell, A. Kriegsheim, 2020, medRxiv.

Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection

A. Casadevall, B. Lau, L. Appel, 2021, medRxiv.

Laparoscopic or open abdominal surgery with thoracotomy for patients with oesophageal cancer: ROMIO randomized clinical trial

V. Save, R. Skipworth, K. Garfield, 2024, The British journal of surgery.